The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Age-Dependent Changes in Metabolism, Contractile Function, and Ischemic Sensitivity in Hearts From db/db Mice
Abstract
Glucose and palmitate metabolism and contractile function were measured with ex vivo perfused working hearts from control (db/+) and diabetic (db/db) female mice at 6, 10–12, and 16–18 weeks of age. Palmitate oxidation was increased by 2.2-fold in 6-week-old db/db hearts and remained elevated in 10- to 12- and 16- to 18-week-old hearts. Carbohydrate oxidation was normal at 6 weeks but was reduced to 27 and 23% of control at 10–12 and 16–18 weeks, respectively. At 6 weeks, db/db hearts exhibited a slight reduction in mechanical function, whereas marked signs of dysfunction were evident at 10–12 and 16–18 weeks. Mechanical function after ischemia-reperfusion was examined in hearts from male mice; at 6 weeks, db/db hearts showed normal recovery, whereas at 12 weeks it was markedly reduced. Fatty acid oxidation was the predominant substrate used after reperfusion. Thus, diabetic db/db hearts exhibit signs of a progressive cardiomyopathy; increased fatty acid oxidation preceded reductions in carbohydrate oxidation. Postischemic recovery of function was reduced in db/db hearts, in parallel with age-dependent changes in normoxic contractile performance. Finally, peroxisome proliferator-activated receptor-α treatment (3 weeks) did not affect sensitivity to ischemia-reperfusion, even though carbohydrate oxidation was increased and palmitate oxidation was decreased.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus isolated working hearts from db/db mice exhibit reduced recovery following ischemia and reperfusion after diabetes develops, but recovery is normal in the pre-diabetic stage (3).”
From Cardiac remodeling in obesity (2008) · cites this paper as [3]
In the citing paper
“Treatment with PPAR-γ or PPAR-α agonists while improving myocardial substrate utilization did not increase postischemic recovery in db/db hearts (3, 36), but acute treatment with high concentrations of glucose and insulin, which substantially increased glucose oxidation rates, increased postischemic recovery and cardiac efficiency (90).”
From Cardiac remodeling in obesity (2008) · cites this paper as [3]
Citations
Cites
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
A novel mouse model of lipotoxic cardiomyopathy
Chiu, H.-C., Kovács, A., Ford, D. A., Hsu, F., Garcia, R. A., Herrero, P., Saffitz, J. E., & Schaffer, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10947 · Cited by 762
Regulation of energy substrate metabolism in the diabetic heart
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00047-3 · Cited by 480
Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
Belke, D. D., Larsen, T. S., Gibbs, E. M., & Severson, D. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1104 · Cited by 401
Self-citationCavaghan, M. K., Ehrmann, D. A., & Polonsky, K. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10761 · Cited by 363
Diabetes-Obesity Syndromes in Mice
Coleman, D. L. (1982) · Diabetes · doi:10.2337/diab.31.1.s1 · Cited by 354
Tomlinson, K., Gardiner, S. M., Hebden, R. A., & Bennett, T. M. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00059-6 · Cited by 321
Eriksson, U. J., Dahlstrom, E., Larsson, K., & Hellerström, C. (1982) · Diabetes · doi:10.2337/diab.31.1.1 · Cited by 310
Yue, T.-L., Chen, J., Bao, W., Narayanan, P. K., Bril, A., Jiang, W., Lysko, P. G., Gu, J.-L., Boyce, R., Zimmerman, D. M., et al. (2001) · Circulation · doi:10.1161/hc4601.099403 · Cited by 295
Cited by
Sorted by citations
Items 101–200 of 279
Type 2 diabetes, mitochondrial biology and the heart
Sack, M. N. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.001 · Cited by 53
Protective effects of desacyl ghrelin on diabetic cardiomyopathy
Pei, X. M., Yung, B. Y., Yip, S. P., Chan, L., Wong, S. C. C., Ying, M. T. C., & Siu, P. M. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0637-4 · Cited by 52
Oakes, N. D., Thalén, P., Aasum, E., Edgley, A. J., Larsen, T. S., Furler, S. M., Ljung, B., & Severson, D. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00233.2005 · Cited by 52
Self-citationThe interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy
Sanganalmath, S. K., Dubey, S., Veeranki, S., Narisetty, K. K., & Krishnamurthy, P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01755-1 · Cited by 55
Mancusi, C., Losi, M. A., Izzo, R., Canciello, G., Manzi, M. V., Sforza, A., LUCA, N. D., Trimarco, B., & SIMONE, G. D. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2016.88 · Cited by 50
Boardman, N., Hafstad, A. D., Larsen, T. S., Severson, D. L., & Aasum, E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01264.2008 · Cited by 49
Self-citationTanajak, P., Sa‐nguanmoo, P., Wang, X., Liang, G., Li, X., Jiang, C., Chattipakorn, S. C., & Chattipakorn, N. (2016) · Acta Physiologica · doi:10.1111/apha.12698 · Cited by 49
Peroxisome proliferator‐activated receptors and inflammation: take it to heart
Smeets, P., Planavila, A., Vusse, G. J., & van Bilsen, M. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01752.x · Cited by 49
The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney
Pulakat, L., DeMarco, V. G., Whaley‐Connell, A. T., & Sowers, J. R. (2011) · Cardiorenal Medicine · doi:10.1159/000327140 · Cited by 48
Cheng, X., Hu, J., Ya, W., Ye, H., Li, X., Gao, Q. F., & Li, Z. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3071959 · Cited by 48
ANZAWA, R., Bernard, M., Tamareille, S., Baetz, D., Sylviane Confort-gouny, A., Gascard, J., Cozzone, P. J., & Feuvray, D. (2006) · Diabetologia · doi:10.1007/s00125-005-0091-5 · Cited by 48
Li, R., Yang, J., Yang, Y., Ma, N., Jiang, B., Sun, Q.-W., & Li, Y. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-141 · Cited by 47
McGill, J. B., Peterson, L. R., Herrero, P., Saeed, I. M., Recklein, C. L., Coggan, A. R., DeMoss, A. J., Schechtman, K. B., Dence, C. S., & Gropler, R. J. (2011) · Journal of Nuclear Cardiology · doi:10.1007/s12350-011-9362-3 · Cited by 48
Xue, Y., Miao, Q., Zhao, A., Zheng, Y., Zhang, Y., Wang, P., Kallio, H. P. T., & Yang, B. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.04.041 · Cited by 47
Chen, H., Shen, W., Wang, X., Chen, H., Gu, J., Fu, J., Ni, Y., Gao, P., Zhu, D., & Higashino, H. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04463.x · Cited by 47
Obesity and insulin resistance: Effects on cardiac structure, function, and substrate metabolism
Peterson, L. R. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0022-y · Cited by 44
Thaung, H. P. A., Baldi, J. C., Wang, H.-Y., Hughes, G., Cook, R. F., Bussey, C. T., Sheard, P. W., Bahn, A., Jones, P. P., Schwenke, D. O., et al. (2015) · Diabetes · doi:10.2337/db14-0955 · Cited by 45
Ca2+ mishandling and cardiac dysfunction in obesity and insulin resistance: Role of oxidative stress
Carvajal, K., Balderas‐Villalobos, J., Bello-Sánchez, M. D., Phillips-Farfán, B. V., Molina-Muñoz, T., Aldana-Quintero, H. A., & Gómez-Viquez, N. L. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.08.003 · Cited by 46
Losi, M. A., Izzo, R., Mancusi, C., Wang, W., Roman, M. J., Lee, E. T., Howard, B. V., Devereux, R. B., & SIMONE, G. D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071044 · Cited by 44
Metabolic Therapy at the Crossroad: How to Optimize Myocardial Substrate Utilization?
Kolwicz, S. C., & Tian, R. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.12.005 · Cited by 43
Cardiac cell death in early diabetes and its modulation by dietary fatty acids
Ghosh, S., & Rodrigues, B. B. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.08.010 · Cited by 43
Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
Welch, M. J., Lewis, J. S., Kim, J., Sharp, T. L., Dence, C. S., Gropler, R. J., & Herrero, P. (2006) · PubMed · Cited by 43
L-3-11C-Lactate as a PET Tracer of Myocardial Lactate Metabolism: A Feasibility Study
Herrero, P., Dence, C. S., Coggan, A. R., Kisrieva-Ware, Z., Eisenbeis, P. E., & Gropler, R. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.044503 · Cited by 42
Kosmala, W., Wong, C. Y., Kuliczkowska-Płaksej, J., Leano, R., Przewłocka‐Kosmala, M., & Marwick, T. H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.12.034 · Cited by 41
Kerr, M. J., Dodd, M. S., & Heather, L. C. (2017) · Clinical Science · doi:10.1042/cs20160671 · Cited by 40
Gender‐dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice
Shimoni, Y., Chuang, M., Abel, E. D., & Severson, D. L. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055590 · Cited by 39
Self-citationBelke, D. D., & Severson, D. L. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-068-7_4 · Cited by 38
Self-citationRisk Factors Preceding Type 2 Diabetes and Cardiomyopathy
Singh, S., Dhingra, S., Ramdath, D. D., Vasdev, S., Gill, V. D., & Singal, P. K. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9197-3 · Cited by 41
Zhu, H., Wang, D., Yan, J., & Xu, J. (2015) · PubMed Central · Cited by 38
Myocardial metabolism and cardiac performance in obesity and insulin resistance
Banerjee, S., & Peterson, L. R. (2007) · Current Cardiology Reports · doi:10.1007/bf02938341 · Cited by 37
Aasum, E., Cooper, M., Severson, D. L., & Larsen, T. S. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-139 · Cited by 37
Self-citationDiabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction
Hegyi, B., Hernández, J. M., Ko, C. Y., Hong, J., Shen, E. Y., Spencer, E. R., Smoliarchuk, D., Navedo, M. F., Bers, D. M., & Bossuyt, J. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027164 · Cited by 39
Desrois, M., Clarke, K. J., Lan, C., Dalmasso, C., Cole, M. A., Portha, B., Cozzone, P. J., & Bernard, M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00998.2009 · Cited by 37
Metabolic (In)Flexibility of the Diabetic Heart
Larsen, T. S., & Aasum, E. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6083-1 · Cited by 37
Self-citationMahmoud, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4307-9_12 · Cited by 37
Animal Models of Dysregulated Cardiac Metabolism
Bugger, H., Byrne, N. J., & Abel, E. D. (2022) · Circulation Research · doi:10.1161/circresaha.122.320334 · Cited by 37
Elmariah, S., Farrell, L. A., Furman, D., Lindman, B. R., Shi, X. D., Morningstar, J. E., Rhee, E. P., & Gerszten, R. E. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4873 · Cited by 37
Ellis, A., Cheng, Z.-J., Li, Y., Jiang, Y. F., Yang, J., Pannirselvam, M., Ding, H., Hollenberg, M. D., & Triggle, C. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.042 · Cited by 36
Medikayala, S., Piteo, B., Zhao, X., & Edwards, J. G. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00248.2010 · Cited by 36
Wilson, K. D., Li, Z., Wagner, R. A., Yue, P., Tsao, P. S., Nestorova, G. G., Huang, M., Hirschberg, D. L., Yock, P. G., Quertermous, T., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002609 · Cited by 36
Finck, B. N. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000134371.70815.32 · Cited by 36
Chen, H., Wu, X.-J., Lu, X., Zhu, L., Wang, L., Yang, H., Chen, H., & Yuan, W.-J. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00113.x · Cited by 35
de Giusti, C. J., Palomeque, J., & MATTIAZZI, A. R. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02650-y · Cited by 35
Koka, S., Xi, L., & Kukreja, R. C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0249-5 · Cited by 34
Janković, D., Winhofer, Y., Promintzer‐Schifferl, M., Wohlschläger‐Krenn, E., Anderwald, C. H., Wolf, P. S., Scherer, T., Reiter, G., Trattnig, S., Luger, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050077 · Cited by 31
GIT2 Acts as a Systems-Level Coordinator of Neurometabolic Activity and Pathophysiological Aging
Martin, B., Chadwick, W., Janssens, J., Premont, R. T., Schmalzigaug, R., Becker, K. G., Lehrmann, E., Wood, W. H., Zhang, Y., Siddiqui, S., et al. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00191 · Cited by 34
Protective effect of resveratrol and quercetin on in vitro-induced diabetic mouse corpus cavernosum
Boydens, C., Pauwels, B., Daele, L. V., & de Voorde, J. V. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0366-9 · Cited by 33
PET Measurements of Myocardial Glucose Metabolism with 1-11C-Glucose and Kinetic Modeling
Herrero, P., Kisrieva-Ware, Z., Dence, C. S., Patterson, B. W., Coggan, A. R., Han, D., Ishii, Y., Eisenbeis, P. E., & Gropler, R. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037598 · Cited by 33
Shearer, J., Ross, K. D., Hughey, C. C., Johnsen, V. L., Hittel, D. S., & Severson, D. L. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00525.2010 · Cited by 32
Self-citationImpact of Obesity-Related Inflammation on Cardiac Metabolism and Function
Larsen, T. S., & Jansen, K. M. (2021) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2021.10.1.8 · Cited by 31
Self-citationMyocardial fatty acid utilization as a determinant of cardiac efficiency and function
Jaswal, J. S., & Ussher, J. R. (2009) · Clinical Lipidology · doi:10.2217/clp.09.18 · Cited by 29
Established and Emerging Mechanisms of Diabetic Cardiomyopathy
Gollmer, J., Zirlik, A., & Bugger, H. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.1.26 · Cited by 31
Targeting caveolin-3 for the treatment of diabetic cardiomyopathy
Murfitt, L., Whiteley, G., Iqbal, M. M., & Kitmitto, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.002 · Cited by 29
Qian, C., Gong, L., Yang, Z., Chen, W., Chen, Y., Xu, Z., Wu, B., Tang, C., Gao, F., & Zeng, W. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0046-9 · Cited by 28
Downregulation in GATA4 and Downstream Structural and Contractile Genes in the db/db Mouse Heart
Broderick, T. L., Jankowski, M., Wang, D., Danalache, B. A., Parrott, C. R., & Gutkowska, J. (2012) · ISRN Endocrinology · doi:10.5402/2012/736860 · Cited by 28
Yeung, C., Lo, A., Cheung, A. K. H., Chung, S. S. M., Wong, D., & Chung, S. K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22349 · Cited by 28
The Function of Heparanase in Diabetes and its Complications
Wang, F., Wan, A., & Rodrigues, B. B. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.05.008 · Cited by 27
Proteomic analysis of mitochondrial proteins in a mouse model of type 2 diabetes
Essop, M. F., Chan, W. A., & Hattingh, S. (2011) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2010-058 · Cited by 27
RETRACTED: Epicardial adipose tissue and cardiac lipotoxicity: A review
Mukherjee, A. G., Renu, K., Gopalakrishnan, A. V., Jayaraj, R., Dey, A., Vellingiri, B., & Ganesan, R. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121913 · Cited by 27
RetractedBanke, N. H., & Lewandowski, E. D. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.10.015 · Cited by 28
Ye, Y., Qian, J., Castillo, A. C., Ling, S., Ye, H., Perez-Polo, J. R., Bajaj, M., & Birnbaum, Y. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00609.2012 · Cited by 27
Ding, H., Howarth, A. G., Pannirselvam, M., Anderson, T. J., Severson, D. L., Wiehler, W. B., Triggle, C. R., & Tuana, B. S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00037.2005 · Cited by 26
Self-citationAnzawa, R., Seki, S., Nagoshi, T., Taniguchi, I., Feuvray, D., & Yoshimura, M. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-33 · Cited by 26
Carley, A. N., & Severson, D. L. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6088-9 · Cited by 26
Self-citationAdenine nucleotide-mediated regulation of hepatic PTP1B activity in mouse models of type 2 diabetes
Yang, X., Zhao, Y., Sun, Q., Yang, Y., Gao, Y., Ge, W., Liu, J., Xu, X., Weng, D., Wang, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-04971-1 · Cited by 24
Boardman, N. T., Aronsen, J. M., Louch, W. E., Sjaastad, I., Willoch, F., Christensen, G., Sejersted, O. M., & Aasum, E. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00741.2013 · Cited by 23
Self-citationPanagia, M., Schneider, J. E., Brown, B. B., Cole, M. A., & Clarke, K. (2007) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y07-028 · Cited by 23
Franekova, V., Angın, Y., Hoebers, N., Coumans, W. A., Simons, P. J., Glatz, J. F. C., Luiken, J. J. F. P., & Larsen, T. S. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00073.2014 · Cited by 22
Self-citationA synthetic free fatty acid-regulated transgene switch in mammalian cells and mice
Liu, Y., Hamri, G. C., Ye, H., & Fussenegger, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky805 · Cited by 23
Asrih, M., Lerch, R. A., Papageorgiou, I., Pellieux, C., & Montessuit, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00427.2011 · Cited by 22
van den Brom, C. E., Bulte, C. S. E., Loer, S. A., Bouwman, R. A., & Boer, C. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-42 · Cited by 24
Boardman, N. T., Hafstad, A. D., Lund, J., Rossvoll, L., & Aasum, E. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00382.2017 · Cited by 22
Self-citationDeng, W., Leu, H., Chen, Y., Chen, Y., Epperson, C. M., Juang, C., & Wang, P. H. (2014) · Endocrinology · doi:10.1210/en.2013-1817 · Cited by 22
Shearer, J., Severson, D. L., Su, L., Belardinelli, L., & Dhalla, A. K. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143594 · Cited by 20
Self-citationEnhancing fatty acid oxidation negatively regulates PPARs signaling in the heart
Liu, Z., Ding, J., McMillen, T. S., Villet, O. M., Tian, R., & Shao, D. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.06.008 · Cited by 20
Cardiovascular consequences of obesity and targets for treatment
Mittendorfer, B., & Peterson, L. R. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.07.001 · Cited by 20
Hicks, S. D., Labinskyy, N., Piteo, B., Laurent, D., Mathew, J., Gupte, S. A., & Edwards, J. G. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00567.2012 · Cited by 20
Cardiac energy metabolism in diabetes: emerging therapeutic targets and clinical implications
Panwar, A., Malik, S. O., Adib, M., & Lopaschuk, G. D. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00615.2024 · Cited by 19
Protection of the abnormal heart
Pantos, C. I., Mourouzis, I. S., & Cokkinos, D. V. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9036-z · Cited by 19
Reyes, M., Steinhelper, M. E., Alvarez, J. A., Escobedo, D., Pearce, J. A., Valvano, J. W., Pollock, B. H., Wei, C., Kottam, A. T. G., Altman, D., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00609.2005 · Cited by 19
Cassano, V., Miceli, S., Armentaro, G., Mannino, G. C., Fiorentino, T. V., Perticone, M., Succurro, E., Hribal, M. L., Andreozzi, F., Perticone, F., et al. (2022) · Nutrients · doi:10.3390/nu14061299 · Cited by 20
Overnutrition and the Cardiorenal Syndrome: Use of a Rodent Model to Examine Mechanisms
Whaley‐Connell, A. T., Pulakat, L., DeMarco, V. G., Hayden, M. R., Habibi, J., Henriksen, E. J., & Sowers, J. R. (2011) · Cardiorenal Medicine · doi:10.1159/000322827 · Cited by 18
Obesity and Preclinical Changes of Cardiac Geometry and Function
Sung, J. K., & Kim, J. (2010) · Korean Circulation Journal · doi:10.4070/kcj.2010.40.2.55 · Cited by 18
Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy
Kain, V., & Halade, G. V. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00031 · Cited by 21
NADPH Oxidase 2 Mediates Myocardial Oxygen Wasting in Obesity
Hafstad, A. D., Hansen, S. S., Lund, J., Santos, C. X. C., Boardman, N. T., Shah, A. M., & Aasum, E. (2020) · Antioxidants · doi:10.3390/antiox9020171 · Cited by 18
Self-citationFaulkner, A., Dang, Z., Avolio, E., Thomas, A. C., Batstone, T., Lloyd, G. R., Weber, R. J. M., Najdekr, L., Jankevics, A., Dunn, W. B., et al. (2020) · Cells · doi:10.3390/cells9051283 · Cited by 17
Kirsti Ytrehus, B. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.10.013 · Cited by 17
Myocardial Insulin Resistance: An Overview of Its Causes, Effects, and Potential Therapy
Toit, E. F. D., & Donner, D. G. (2012) · InTech eBooks · doi:10.5772/50619 · Cited by 18
Boardman, N. T., Larsen, T. S., Severson, D. L., Essop, M. F., & Aasum, E. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01190.2010 · Cited by 17
Self-citationJansen, K. M., Moreno, S., García-Rovés, P. M., & Larsen, T. S. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00191.2019 · Cited by 17
Self-citationA new mouse model of metabolic syndrome and associated complications
Wang, Y., Zheng, Y., Nishina, P. M., & Naggert, J. Κ. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0079 · Cited by 17
Astonishing advances in mouse genetic tools for biomedical research
Jackson, W. S., & Kaczmarczyk, L. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14186 · Cited by 15
Donner, D. G., Elliott, G. E., Beck, B. R., Bulmer, A. C., Lam, A. K.-Y., Headrick, J. P., & Toit, E. F. D. (2015) · Endocrinology · doi:10.1210/en.2015-1603 · Cited by 16
Progressive Decrease in Coronary Vascular Function Associated With Type 2 Diabetic Heart Disease
Katare, R., Pearson, J. T., Lew, K. S., Wei, M., Tsuchimouchi, H., Du, C., Zhan, D., Umetani, K., Shirai, M., & Schwenke, D. O. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00696 · Cited by 16
Ounzain, S., Kobayashi, S., Peterson, R. E., He, A., Motterle, A., Samani, N. J., Menick, D. R., Pu, W. T., Liang, Q., & Chong, N. W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06374-11 · Cited by 15
Boardman, N. T., Pedersen, T. M., Rossvoll, L., Hafstad, A. D., & Aasum, E. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00284.2020 · Cited by 15
Self-citationder Mieren, G. V., Nevelsteen, I., Vanderper, A., Oosterlinck, W., Flameng, W. J., & Herijgers, P. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-89 · Cited by 15
Lasheras, J., Vilà, M., Zamora, M., Riu, E., Pardo, R., Poncelas, M., Cases, I., Ruiz‐Meana, M., Hernández, C., Felíu, J. E., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.04.004 · Cited by 15
Ko, K., Wu, Y., Liu, C., Cheng, M., Yen, R., & Yang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.21202 · Cited by 15
Cardioprotective effect of the PPAR ligand tetradecylthioacetic acid in type 2 diabetic mice
Khalid, A. M., Hafstad, A. D., Larsen, T. S., Severson, D. L., Boardman, N., Hagve, M., Berge, R. K., & Aasum, E. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00357.2010 · Cited by 14
Self-citation
Metadata
- Authors
- Aasum, E., Hafstad, A. D., Severson, D. L., & Larsen, T. S.
- Affiliations
- UiT The Arctic University of Norway (NO)
- University of Calgary (CA)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-02-01
- Volume
- 52
- Issue
- 2
- Pages
- 434-441
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2150336836
- Cited by
- 280
- References
- 53
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 10 · 2023: 7 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 9 · 2018: 12 · 2017: 10 · 2016: 6 · 2015: 17 · 2014: 13 · 2013: 10 · 2012: 21
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Norges Forskningsråd
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- db/db mice, type 2 diabetes, diabetic cardiomyopathy, myocardial metabolism, palmitate oxidation, fatty acid oxidation, carbohydrate oxidation, cardiac contractile function, ischemia-reperfusion injury, age-related changes, PPARα
- MeSH terms
- Aging, Animals, Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Heart, Hemodynamics, Insulin, Mice, Inbred C57BL, Mice, Mutant Strains, Myocardial Contraction, Myocardium, Organ Size, Oxidation-Reduction, Myocardial Ischemia, Carbohydrate Metabolism, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review